The endotoxin-altering activity of fractions isolated from normal horse serum was examined by incubation of Salmonella typhosa strain 0-901 endotoxin (Boivin) in a solution of the fraction, and subsequent quantitation of any diminution in the capacity of endotoxin to be precipitated by specific anti-endotoxin antiserum. The horse serum fraction isolated by precipitation with ammonium sulfate at a concentration between 1.6 and 2.7 M was incubated with Pronase PA and then with trypsin.
eluted with 0.2 M tris(hydroxymethyl)aminomethane buffer, most of the endotoxinaltering activity was found in the first protein peak designated F-la. F-la was found to be homogeneous and corresponded to an a2-macroglobulin by the techniques of electrophoresis, immunodiffusion, and ultracentrifugation. Approximately 100-fold more F-la than endotoxin was needed to reduce the antigenicity of the endotoxin by one-half. Alteration was increased when F-la was incubated with the endotoxin at acid pH or at 45 C rather than at 37 C and was lost after heating F-la at 56 C for 30 min. N-ethylmaleimide increased the endotoxin-altering activity of horse serum, F-la, and human plasma fraction 1110, whereas p-chloromercuribenzoate did not. On the other hand, diazonium-l-H-tetrazole, iodoacetic acid, and benzylchloride suppressed the activity of F-la. When the interaction of endotoxin and F-la was examined by immunodiffusion techniques, depolymerization of the endotoxin molecule was indicated. The endotoxin-altering factor of horse serum is discussed in relation to the mechanisms of other known reagents, such as deoxycholate and sodium lauryl sulfate.
Human serum or plasma components, which decrease in vitro the antigenic and biological properties of bacterial endotoxin, have been found in Cohn's fractions 11o and IV1 (21) , and in an a1-lipoprotein and a,-globulin esterase (16) . Moreover, bile salts present in the plasma have been suggested as major active components (12) . A variety of reagents other than those of blood origin, including mild acid hydrolysis, have also been shown to degrade the endotoxin molecule nonspecifically, e.g., papain (7), bromelin (22) , liver extract (9) , dodecyl sulfate (1), acetylation (3, 8) , and ionizing radiation (11) .
Whether identical or diverse chemical sites of the endotoxin molecule are affected by these various treatments is not known.
An endotoxin-depolymerizing effect of some of these reagents has been postulated and related to the decrease in serological or biological activity after observations by immunodiffusion (14, 16) , centrifugation (1, 18) , and electron microscopy (12) . Inactivation of endotoxin by human serum was reported to be reversible (14) , and serological or biological activity of endotoxin was restored after repolymerization of dispersed subunits (12) .
In a previous publication (22) , an endotoxinaltering factor (EAF) from horse serum was obtained by fractionation with ammonium sulfate. The activity of EAF was inhibited with the addition of iodoacetic acid, benzyl chloride, 6-iodoso- benzoic acid or guanidine compounds, and a possible role of sulfhydryl groups in EAF was postulated. To obtain more definitive information on endotoxin detoxification by EAF, further purification of the active ammonium sulfate fraction by using proteolytic enzyme digestion of EAF and gel diffusion analysis was carried out. a2-Macroglobulin was found to comprise a 432 YOSHIOKA major part of EAF. The characteristics of this fraction are described.
MATERIALS AND METHODS
The procedure for preparation of endotoxin from a stock strain of Salmonella typhosa 0-901 with trichloroacetic acid extraction and the quantitative precipitin reaction, as applied to the analysis of antigen (endotoxin), have been described previously (21) . In the latter, EAF Enzyme treatment of fr. B2. Fr. B2 was consistently found to contain a major part of the EAF present in the original serum. Accordingly, it was subjected to partial degradation with Pronase and trypsin before further fractionation. Since the two enzymes used were shown to inactivate EAF (22) , the conditions of enzyme treatment were altered so as not to give any appreciable decrease in EAF activity of fr. B2, but still to achieve limited proteolysis. Towards (LKB 6520) . The EAF activity was found solely in the first protein peak (F-1). F-1 was reeluted through the same column, and the main protein fraction was collected and termed F-la.
Preparation of antiserum. F-la in saline solution, or the original horse serum, was mixed well with an equal amount of incomplete Freund Adjuvant (Difco) by using 20 mg of F-la or 0.5 ml of horse serum, and the mixture was injected subcutaneously once into a foot pad of rabbits. All animals were bled 1.5 months later. Sera were separated and frozen at -20 C after Merthiolate was added.
Polyacrylamide gel electrophoresis. A method modified by Tachibana and Yamamura (19) was employed. Twenty milliliters of 10% cyanogum (polyacrylamide) 41, 0.04 ml of EMAPN (both from Seikagaku Industrial Co., Tokyo), 25 ml of Triscitrate buffer (4.65 g of triaminomethane and 0.5 g of citric acid were made to 1 liter with distilled water), 40 mg of ammonium persulfate, and 5 ml of deionized water were solidified in a container (123 by 108 by 3 mm). Samples were applied in small troughs (7 mm in diameter) were cut in the agar layer 2 mm thick. Proper amounts of antigen and antiserum were added, and the gel was kept in a humid chamber at room temperature for a period of 5 to 7 days.
Immunoelectrophoresis. A glass plate (7.7 by 5.3 cm) was used as a support for 8 ml of 1.5% J Agar dissolved in Veronal buffer (pH 8.2; ionic strength, 0.05) containing a 0.1% concentration of Merthiolate. Antigens were applied into small wells in an amount of 0.005 ml each. Electrophoretic separation was obtained in 4 to 5 hr with a potential gradient of 4 v/cm and a current of 2 to 2.5 ma/cm at room temperature. The troughs (1.2 by 80 mm) made between antigen spots were each filled with 0.2 ml of the indicated antisera. The precipitin reaction was developed in a humid chamber at room temperature for a period of 5 to 7 days. The plate was washed in 0.15 M saline solution for 3 to 4 days and air-dried.
Ultracentrifugation analysis. Sedimentation velocity. analyses were conducted with a Spinco model E analytical ultracentrifuge at 52,000 rev/min and a temperature of 20 C by using schlieren optics. PBS (pH 7.0 i 0.03) was employed as a solvent. Photographs were taken at 8-min intervals. Analyses were kindly carried out by T. Nagumo of the Kitasato University School of Hygienic Sciences, Tokyo.
Heat sensitivity test of F-la activity. Portions of F-la solution were kept for 30 min at 4, 30, 37, 45, 56, or 60 C before the addition of endotoxin. In other experiments, sample mixtures of F-la and endotoxin were subjected to incubation over a similar temperature range as employed above for 4 hr and were assayed for EAF activity.
Effect of pH on F-la activity. Routine EAF potency assays were performed at pH 7.0. The pH of the mixture of F-la and endotoxin was adjusted with 0.1 N HCl or NaOH solution over the range of 4.0 to 8.0 at intervals of 1.0 unit and also to 9.4, and the mixture was incubated at 37 C for 4 hr. Each mixture was neutralized to pH 7.0 before the addition of anti-S. typhosa serum for the quantitative precipitin reaction.
N-ethylmaleimide (NEM) treatment. NEM (Tokyo Kasei Industrial Co., Tokyo) was dissolved in water at the various concentrations indicated in the text. F-la material was mixed with NEM solution at 37 C for 60 min and then assayed for EAF activity.
Diazonium-l-H-tetrazole (DHT) treatment. DHT solution was prepared by the method of Horinishi et al. (5), as follows. A 0.3-g amount of 5-amino-l-H-tetrazole (Seikagaku Industrial Co., Tokyo) was dissolved in 6 ml of water, and 0.9 ml of HCI was added. Separately, 207 mg of NaNO2 was dixsolved in 3 ml of water. Both solutions were mixed well at 0 C, and the pH level was adjusted to 5 with concentrated KOH solution (DHT solution). Appropriate amounts of F-la were dissolved in 0.67 M NaHCOs solution (pH 9.0) and added to DHT solution at final concentrations of 6 X 10-3, 3 X 10-3, or 6 X 10-4 M. The mixture (pH 8.8) was incubated at 0 C for 60 min and then dialyzed against 0.007 M PB. The fluid in the dialysis tubing was assayed for EAF activity.
Pronase treatment of the incubated endotoxin with F-la mixture. Endotoxin was incubated with F-la solution plus 0.08 M NEM as described previously, after which Pronase-PA solution was added in various portions, and incubation was continued at 37 C for an additional 4 hr. Enzyme activity was stopped with EDTA, and endotoxin was assayed by the quantitative precipitin reaction.
Pyrogenicity test. Male, white rabbits approximately 8 weeks old were used. Normal rectal temperatures were repeatedly measured with a model STM-005-2 thermometer (Takara Thermistor Instruments Co., Tokyo) for several days before the injection of materials. Rabbits with a normal body temperature between 38.9 and 39.8 C were used for pyrogenicity tests. The diluted testing materials, which contained 1 ug of endotoxin if no alteration was assumed, were injected intravenously into groups of two rabbits for each material. Rectal temperatures were measured every 30 min for 4 to 5 hr after the injection.
RESULTS
The protein elution pattern of a horse serum sample (fr. B2) digested with Pronase PA and trypsin, followed by Sephadex G-200 chromatography, is seen in Fig. 1 . Repeated trials of many serum samples produced quite similar patterns, all being characterized by three major and one minor peaks. When the first peak (F-1) was reeluted through the same column, the resulting F-la pattern showed a single symmetric peak without appreciable shoulders. Representative data testing all peaks and the ammonium sulfate fractions for EAF activity are shown in fractions and human plasma fractions against F-la antiserum. Well 1, F-la, 0.5 mg/ml; well 2, fr. B2, 0.5 mg/ml; well 3, human fr. IIlo, 3 mg/ml; well 4, horse serum, diluted fourfold; well 5, human fr. IV1, 4 mg/ml; well A, anti-F-la rabbit serum.
of the EAF found in fr. B2, whereas other fractions showed little or no activity. The relative activity of fr. B2 and F-la, as compared to the original serum, was approximately 4-fold and 12-fold on a nitrogen basis, respectively. Nearly 80% of the activity of the original serum was concentrated in fr. B2, whereas 54 to 68% was found in F-la. F-la, stored in a dried state for several months at -20 C, exhibited EAF potency equal to that of freshly prepared samples; its activity began to decline somewhat after 6 months.
Electrophoretic analysis. Paper and polyacrylamide electrophoresis of the fractions were comparable, and the latter pattern is seen in Fig. 2 . Fr. A1 was composed mainly of albumin and (3-globulins, fr. B1 of a-globulin, and fr. B2 of a-and :-globulins. By both techniques, a single protein band which corresponds to a-macroglobulin was recognized in the F-la sample. When a serum sample which was not treated with the enzymes was chromatographed, additional proteins contaminated the electrophoresis pattern. By the Ouchterlony agar diffusion method ( Fig. 3) with F-la antiserum in the center well, the antigens F-la and fr. B2 showed a single, identical sharp precipitin arc. The original serum as antigen resulted in a clear arc similar to that of the F-la antigen and several rather diffuse precipitin lines. It may be observed in Fig. 4 that, even when using a strong antiserum against whole horse serum, F-la showed only a single precipitin arc, whereas fr. B2 resulted in a diffuse arc in addition to a sharp one which fused with Well A, rabbit anti-horse serum; well B, rabbit anti-F-la serum; well 1, horse serwn; well 2, F-la; well 3, fr. B2.
that of F-la. Horse serum, the homologous antigen, resulted in many arcs, as expected. In this figure, also, is revealed a line of identity between an antigen in human serum fractions 11o and IV, (Cohn, method 10), but this antigen was different from that of F-la and fr. B2. In the EAF assay, only fr. Illo, but not fr. IV1, strongly diminished the antigenicity of the S. typhosa endotoxin. F-la formed a clear precipitin arc with anti-human a2-macroglobulin rabbit serum (Behringswerke AG, Germany), and the arc fused with that made between F-la and anti-F-la rabbit serum. However, anti-human IgM rabbit serum did not give rise to a precipitin arc with F-la. The immunoelectrophoretic patterns in Fig. 5 between antigen F-la or fr. B2 and F-la anti-horse serum are compatible with those seen by agar diffusion. Here, again, the F-la homologous antibody arc corresponded in position to a2-globulin.
Ultracentrifugation pattern. Figure 6 shows the ultracentrifugation patterns of sedimentation velocity runs for F-la eluted from enzymetreated fr. B2. The S20, value of the single peak was calculated as 18.23.
Negative electron microscopic observation staining with phosphotungstic acid revealed a uniform lattice particle, with a diameter of approximately 15 nm.
Effect of heating on F-la activity. 6 . Ultracentrifugation patterns of 0.5%7c F-la in phosphate-buiffered saline (pH 7.0; ionic strength, 0.1).
The run was at 20.0 i 0.5 C and 52,000 revlmili. Direction of sedimentation is from riglht to left. Pictutres were taken 9, 17 25, and 33 miii after reaching full-speed centrifugation. fore the addition of endotoxin solution, 45 C also was optimum for EAF activity (Table 3) .
Heating at 50 C showed various results with different materials and indicated that stability had begun to wane at this temperature. F-la was not stable at 56 C for 30 min. Effect of pH on F-la activity. Incubation of the F-la endotoxin mixture at a pH range between 4.0 and 9.4 revealed that the lower the pH, a Materials were preincubated with or without NEM at 37 C for 1 hr and then with the endotoxin for four additional hours at the same temperature before the serological assay.
bNot done.
ished EAF activity, and, at 6 X 10-3 M DHT, the antigenicity of endotoxin was completely recovered despite incubation in F-la. Restoration of endotoxin antigenicity from an incubated endotoxin with F-la mixture by treat--/ 4 --.s ment with Pronase. When Pronase was added to F-la at a 1:5 ratio on a weight basis, almost t \ \ b \ 100% of the original antigenicity of the endotoxin was recovered, whereas at a ratio of 1:20 ,-';-----~there was no effect. Fig. 7 . Although the degree of fever ion F-la. 0, Endotoxin control (recovery of increase was not always parallel to the endotoxin toxin in vitro, 100%); X, partial repression by recovery, endotoxin which was rendered sero-'of serum (23%); 0, repression by F-la (75%); logically less active by serum or F-la also was A, repression by F-la (24%). Per cent values in less pyrogenic. ntheses indicate endotoxin recoverable after inChemical analyses of F-la. The total sugar tion.
in F-la samples averaged 7.5 % (phenol-sulfuric acid method), whereas the amino sugar was 40%, (w/v; 22). NEM was used as a reagent 5.0% (Elson-Morgan method). Analyses for Fe a higher affinity to sulfhydryl groups than (o-phenanthrene method), P (ammonium ranae employed before, and NEM strikingly date-molybdate method), Cu and Ca (both igthened the EAF activity of effective frac-emission spectrum analysis) were negative. tions, including human fr. IIo (Table 5 ). pChloromercuribenzoate (PCMB), which is also known to be a specific sulfhydryl reagent, did not affect EAF activity. Increasing the amount of DHT in the F-la solution resulted in dimin-DISCUSSION Several of our findings suggest that EAFendotoxin interaction was different when F-la was used in place of whole serum. Thus, serum was more active at alkaline pH, whereas the activity of F-la was higher at acid pH. Ca or Mg ions were highly inhibitory to the endotoxinaltering activity of serum and human fractions III and IV1, but they did not-affect the activity of F-la. These differences might have occurred because serum also contains an endotoxindisaggregating factor (2, 20) , which increases the pyrogenic or antigenic activity of the endotoxins but does not disrupt it into subunits. Self-aggregation among endotoxin particles, however, may not be too strong, inasmuch as a single addition of citrate or oxalate has been reported to disaggregate endotoxins (20) .
A possible existence of EAF in serum as other than a2-macroglobulin also has not been excluded. By agar diffusion techniques, F-la reacted with only a single precipitin line either with F-la antiserum or with horse serum antiserum. On the other hand, diffusion of horse serum against F-la antiserum resulted in at least four lines. Thus, several antibodies appear to have been produced by trace amounts of serum protein in the major component of F-la, a2-macroglobulin. The content of these minor components in F-la would have been too small to produce visible precipitin lines, but enough was present in whole serum to produce clear reaction lines. Another possibility is that F-la was broken down in vivo during immunization and elicited several antibodies, and the fragments existed in serum as other than F-la and reacted with those antibodies. The precipitin line formed between human plasma fraction IIo or IV1 and F-la antiserum apparently spurred to that formed by F-la. The fraction 11o here employed was highly active as an EAF, but no activity was found in fr. IV,. If the EAF in F-la were antigenic and formed the precipitin line with the F-la antiserum, the EAF in human fr. 11o should not have a component antigenically identical to the F-la. Although F-la-antibody precipitation formed a single line, there is no proof that the EAF itself was the identical substance which produced the precipitin reaction. Moreover, the EAF also could consist of two or more distinct types of substances.
It is questionable whether all the protein in F-la a2-macroglobulin is required for its endotoxinaltering activity. To reduce the antigenicity of the endotoxin by one-half, 100-fold as much F-la, which was approximately 13-fold times as active on a weight basis as that of the original serum, was needed as that of endotoxin. This ratio could be lowered to approximately 10-fold with the addition of NEM to F-la. This ratio should reflect the molecular weights of subunits of both EAF and the endotoxin, carrying the smallest number of reactive sites.
Lyophilized F-la, stored at -20 C, was found stable for approximately 6 months. The F-la solution lost its activity when heated at 56 C for 30 min. Endotoxin alteration was achieved by F-la most efficiently at 45 C rather than at 37 C. Our previous observation (21) using human plasma fr. 11o and fr. IV1, showed the most effective temperature to be 37 C, but Skarnes et al. (17) found that inactivation of Serratia marcescens endotoxin with serum at 45 C was as complete as at 37 C, when examined for capacity to cause tumor damage in mice.
Endotoxins once inactivated with human plasma fr. IV1 (14) , papain (15) , or rabbit liver proteins (9) have been reactivated. These facts suggest that the alteration of endotoxin is not based on hydrolytic cleavage. Recently, Ribi et al. (12) presented evidence that deoxycholate (NaD), a surfactant, depolymerized the endotoxin molecule and reduced molecular size from a complete antigen of about 1,000,000 to a postulated incomplete antigen with a molecular weight of 10,000 to 20,000. They hypothesized that, once depolymerized molecules of endotoxin were released from NaD, prompt reaggregation occurred, as was shown by restoration of pyrogenicity. When a small amount of human plasma was added after the NaD treatment, depolymerized endotoxin molecules did not reaggregate even though NaD was removed by dialysis. If, on the other hand, the adsorbed human plasma was removed by digestion with Pronase, aggregation reoccurred. Similar findings were reported by Oroszlan et al. (9) , who used sodium lauryl sulfate, another detergent, for the dissociation of S. marcescens endotoxin, and by Beer et al. (1) who used sodium dodecyl sulfate and Escherichia coli endotoxin. In the present work, approximately 100% of the endotoxin activity was regained after digestion with Pronase of an inactivated mixture of F-la and endotoxin by the procedure employed by Rudbach and Johnson (14) . This fact suggests that an analogous mechanism was functional with F-la. However, deoxycholates were not detected in F-la by the thin-layer chromatography method of Frosche and Wagener (4) . Slight amounts of two unidentified bile salts and cholesterol were detected. However, dried samples of these three components recovered from an F-la sample appeared not to have any activity on endotoxin.
Sulfhydryl inhibitors, o-iodosobenzoic acid, iodoacetic acid, benzyl chloride, and guanidine salts showed a marked degree of suppression of EAF potency in the horse serum fraction obtained by the salting-out method (22) . NEM is known to be a specific sulfhydryl inhibitor, as is PCMB, although the specificity of NEM is higher (6) . PCMB had no effect on the endotoxinaltering activity of F-la, whereas treatment of the original horse serum, fr. B2, F-la, or human fr. 11o (Cohn) with NEM before the addition of the endotoxin uniformly and strikingly increased the EAF potency. Since use of cysteine hydrochloride, a sulfhydrylamino acid, or NEM alone did not give rise to alteration in the antigenicity of endotoxin, an interaction between free sulfhydryl groups in the protein molecule and sulfhydryl modifiers still remains speculative. In addition, the endotoxin-altering activity of F-la was highly suppressed with DHT, indicating that the histidine residues of F-la were modified. Analysis of active end groups of a2-macroglobulin fragments may lead to a closer understanding of the mechanism of EAF-endotoxin interaction. LITERATURE CITED
